Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy

E-ISSN： 1873-5576|9|8|938-952

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.9, Iss.8, 2009-12, pp. : 938-952

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies

Current Cancer Drug Targets, Vol. 16, Iss. 9, 2016-10 ,pp. : 755-764

Bentham Science Publishers

Access to resources Recommend Favorite

Indoleamine 2,3-dioxygenase, Tregs and Cancer

Current Medicinal Chemistry, Vol. 18, Iss. 15, 2011-05 ,pp. : 2240-2246

Bentham Science Publishers

Access to resources Recommend Favorite

Indoleamine 2,3-Dioxygenase in Immune Suppression and Cancer

Current Cancer Drug Targets, Vol. 7, Iss. 1, 2007-02 ,pp. : 31-40

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Concepts on Inhibitors of Indoleamine 2,3-Dioxygenase in Rheumatic Diseases

Current Medicinal Chemistry, Vol. 19, Iss. 31, 2012-11 ,pp. : 5381-5393

Bentham Science Publishers

Access to resources Recommend Favorite

Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases

By Tan PH Bharath AK

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 8, 2009-08 ,pp. : 987-1012

Informa Healthcare

Access to resources Recommend Favorite